Abstract
As the usual regulatory framework did not fit well during the last Ebola outbreak, innovative thinking still needed. In the absence of an outbreak, randomised controlled trials of clinical efficacy in humans cannot be done, while during an outbreak such trials will continue to face significant practical, philosophical, and ethical challenges. This article argues that researchers should also test the safety and effectiveness of novel vaccines in wild apes by employing a pluralistic approach to evidence. There are three reasons to test vaccines in wild populations of apes: i) protect apes; ii) reduce Ebola transmission from wild animals to humans; and iii) accelerate vaccine development and licensing for humans. Data obtained from studies of vaccines among wild apes and chimpanzees may even be considered sufficient for licensing new vaccines for humans. This strategy will serve to benefit both wild apes and humans.
Highlights
As the usual regulatory framework did not fit well during the last Ebola outbreak, innovative thinking still needed
Recognizing that Ebola poses a common threat to humans and animals, we advocate for a response to Ebola rooted in a One Health approach to infectious disease prevention and control
In the absence of an outbreak, randomized controlled trials of clinical efficacy in humans cannot be done, while during a future outbreak such trials will continue to face significant practical, philosophical, and ethical challenges associated with limiting access to new medicines to the research context when there is an immediate widespread public health crisis (Edwards 2013)
Summary
As the usual regulatory framework did not fit well during the last Ebola outbreak, innovative thinking still needed. This need motivates our call for expanding vaccine research to include study of wild apes and chimpanzees that are at risk of exposure to Ebola virus.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.